Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 11, 2023 - Fresenius Kabi launched an authorized brand alternative of Sanofi/Genzyme’s Mozobil (plerixafor) subcutaneous solution.
Download PDF
Return to publications
